Takeda to build $767m plasma-derived therapies facility in Japan
The new facility, which represents Takeda’s largest-ever investment in manufacturing capacity expansion in Japan, will help meet the…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
24 Mar 23
The new facility, which represents Takeda’s largest-ever investment in manufacturing capacity expansion in Japan, will help meet the…
10 Mar 23
The company is committed to investing at least $400m and intends to start works on the new biosimilars…
The US drugmaker intends to start initial production from the expanded Research Triangle Park this year, with full…
14 Dec 22
"As we continue to focus on our long-term strategic goals, Dawn's focus in the Europe & AMEAP region is on…
05 Dec 22
The investment, which forms part of Pfizer’s strategy to expand manufacturing capacity in Europe, will focus on the…
06 Oct 22
The new Bio-CDMO facility, which is expected to commence operations in financial year 2026, will be capable of…
25 Aug 22
The new facility in Plainville, Massachusetts is intended to manufacture materials central to the production of gene-based therapeutics
31 May 22
The acquisition is expected to expand Evotec’s cell therapy platform EVOcells, an integrated platform for the discovery, development…
24 May 22
The investment will enhance the membrane manufacturing capacities, enables the construction of a new filtration manufacturing facility, and…
11 Apr 22
The recalled vaccines form the lot were supplied in Norway, Poland, Portugal, Spain and Sweden from 13 to…